Omnipotent Biological: It is expected that the net profit will be a loss of 143 million to 167 million yuan by 2025.

Hefei Yuan Biology Announcement: It is expected that the annual total profit will be a loss of 167 million to 143 million yuan in 2025, and the net profit attributable to the owners of the parent company will be a loss of 167 million to 143 million yuan in 2025. During the reporting period, with the approval and market entry of the company's product, Aufulmin, sales revenue has achieved rapid growth. Currently, the smart production lines for the annual production of 10 tons of recombinant human albumin raw liquid and preparation cGMP in the relevant products are still in the capacity climbing period, and the capacity will be gradually released.